Impact of Community Respiratory Viral Infections in Urban Children with Asthma
Overview
Pulmonary Medicine
Authors
Affiliations
Background: Upper respiratory tract viral infections cause asthma exacerbations in children. However, the impact of natural colds on children with asthma in the community, particularly in the high-risk urban environment, is less well defined.
Objective: We hypothesized that children with high-symptom upper respiratory viral infections have reduced airway function and greater respiratory tract inflammation than children with virus-positive low-symptom illnesses or virus-negative upper respiratory tract symptoms.
Methods: We studied 53 children with asthma from Detroit, Michigan, during scheduled surveillance periods and self-reported respiratory illnesses for 1 year. Symptom score, spirometry, fraction of exhaled nitric oxide (FeNO), and nasal aspirate biomarkers, and viral nucleic acid and rhinovirus (RV) copy number were assessed.
Results: Of 658 aspirates collected, 22.9% of surveillance samples and 33.7% of respiratory illnesses were virus-positive. Compared with the virus-negative asymptomatic condition, children with severe colds (symptom score ≥5) showed reduced forced expiratory flow at 25% to 75% of the pulmonary volume (FEF), higher nasal messenger RNA expression of C-X-C motif chemokine ligand (CXCL)-10 and melanoma differentiation-associated protein 5, and higher protein abundance of CXCL8, CXCL10 and C-C motif chemokine ligands (CCL)-2, CCL4, CCL20, and CCL24. Children with mild (symptom score, 1-4) and asymptomatic infections showed normal airway function and fewer biomarker elevations. Virus-negative cold-like illnesses demonstrated increased FeNO, minimal biomarker elevation, and normal airflow. The RV copy number was associated with nasal chemokine levels but not symptom score.
Conclusion: Urban children with asthma with high-symptom respiratory viral infections have reduced FEF and more elevations of nasal biomarkers than children with mild or symptomatic infections, or virus-negative illnesses.
Bentley J, Kreger J, Breckenridge H, Singh S, Lei J, Li Y Am J Physiol Lung Cell Mol Physiol. 2024; 327(4):L557-L573.
PMID: 39189801 PMC: 11888781. DOI: 10.1152/ajplung.00149.2023.
Havens T, LeBeau P, Calatroni A, Gern J, OConnor G, Wood R Pediatr Allergy Immunol. 2024; 35(7):e14197.
PMID: 39016335 PMC: 11360514. DOI: 10.1111/pai.14197.
Liu T, Wang Y, Zhang Z, Jia L, Zhang J, Zheng S BMC Pulm Med. 2023; 23(1):258.
PMID: 37452319 PMC: 10347753. DOI: 10.1186/s12890-023-02553-x.
Wang W, Sinha A, Lutter R, Yang J, Ascoli C, Sterk P Viruses. 2022; 14(11).
PMID: 36366542 PMC: 9695046. DOI: 10.3390/v14112444.
Li R, Li Y, Dong X Mol Med Rep. 2020; 22(4):2753-2766.
PMID: 32945411 PMC: 7453612. DOI: 10.3892/mmr.2020.11380.